Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Andrew Haydon"'
Autor:
Adnan Nagrial, David Goldstein, Niall C. Tebbutt, Bert Vogelstein, Joshua D. Cohen, Lu Li, Andrew Haydon, Kenneth W. Kinzler, Koen Simons, Peter Gibbs, Jeanne Tie, Cristian Tomasetti, D W M Tai, Prasad Cooray, Nick Papadopoulos, C L Wolfgang, Matthew Burge, Lara Lipton, Belinda Lee, Mehrdad Nikfarjam, Ammar A. Javed, Marion Harris, Benjamin N. J. Thomson, A M Lennon, B. Lawrence
Publikováno v:
Annals of Oncology. 30:1472-1478
In early-stage pancreatic cancer, there are currently no biomarkers to guide selection of therapeutic options. This prospective biomarker trial evaluated the feasibility and potential clinical utility of circulating tumor DNA (ctDNA) analysis to info
Autor:
Jacqui Adams, M.M.K. Chan, Ray Asghari, Xanthi Coskinas, Karen Briscoe, Michael Millward, Theresa Hayes, A. Davidson, A. Tognela, Matthew T. V. Chan, Susan Tiley, Nick Muljadi, Vy. Broaddge, Catherine Crombie, Mohammed Islam, N. Pavlakis, Ray M. Lowenthal, Andrew Davidson, Rasha Cosman, X. Coskinas, M.R. Stockler, C. Crombie, Robert Blum, Craig R. Lewis, C.R. Lewis, Nick Pavlakis, Adam Boyce, S. Begbie, Martin R. Stockler, Stephen Begbie, David Gibbs, Michael Boyer, Annette Tognela, Steven Ackland, Sue-Anne McLachlan, David Espinoza, Andrew Haydon, E Abdi, B.G.M. Hughes, Girish Mallesara, Jeremy Long, Janette L. Vardy, Adam Broad, J. Long, Kevin Jasas, N. Muljadi, A. Broad, Suresh Vama, S. Chinchen, Victoria J Bray, Anne-Sophie Veillard, S. Varma, M. Boyer, K. Briscoe, E. Abdi, A. Boyce, Brett G.M. Hughes, Sarah Chinchen, Danielle Ferraro
Publikováno v:
Annals of Oncology. 26:2280-2286
Background We sought to determine whether the substantial benefits of topical nitroglycerin with first-line, platinum-based, doublet chemotherapy in advanced nonsmall-cell lung cancer (NSCLC) seen in a phase II trial could be corroborated in a rigoro